The thick fog here up until yesterday has given way to bright, shiny sunshine today. Chief Executive Officer Pascal Soriot, I am glad to meet you here. AstraZeneca’s vaccine is the one Korea has used first and most often to inoculate its people so it carries all the more significance.
Importantly, as the vaccine has been produced in Korea by SK directly through technology transfer, it has helped Koreans feel more secure about receiving shots. In addition, this has enabled Korea to take the important first step toward emerging as a global vaccine production hub. I am deeply grateful to your company.
Thanks to your leadership and bold development of new drugs, it has become possible to quickly develop COVID-19 vaccines. Notably, many countries around the world are benefitting from you having placed a greater focus on supplying vaccines swiftly rather than making them rely on imports.
Korea will actively work together to resolve the global vaccine shortage. I hope that AstraZeneca will also utilize our production capacity, so the world can be supplied vaccines more smoothly. I ask for your special attention so Korea’s inoculation plan can proceed stably.